Kawakami, H., Huang, S., Pal, K., Dutta, S. K., Mukhopadhyay, D., & Sinicrope, F. A. (2016). Mutant BRAF upregulates MCL-1 to confer apoptosis resistance that is reversed by MCL-1 antagonism and cobimetinib in colorectal cancer. Mol Cancer Ther.
Citação norma ChicagoKawakami, Hisato, Shengbing Huang, Krishnendu Pal, Shamit K. Dutta, Debabrata Mukhopadhyay, and Frank A. Sinicrope. "Mutant BRAF Upregulates MCL-1 to Confer Apoptosis Resistance That Is Reversed By MCL-1 Antagonism and Cobimetinib in Colorectal Cancer." Mol Cancer Ther 2016.
MLA CitationKawakami, Hisato, et al. "Mutant BRAF Upregulates MCL-1 to Confer Apoptosis Resistance That Is Reversed By MCL-1 Antagonism and Cobimetinib in Colorectal Cancer." Mol Cancer Ther 2016.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.